Bioscience York is a leading R&D consortium providing access to unique world-class expertise in biotech fields including pharmaceuticals, biomedics/healthcare, food and agriculture. With a critical mass of over 2,000 life-scientists within an 8-mile radius and an annual research budget in excess of $128 M, Bioscience York draws together a diverse range of products and services, varying from drug design to venture capital. Established in 1995 in one of the UK's main centres of bioscience excellence, Bioscience York has developed an extended and growing world-wide network of over 1,400 international organisations who are keen to keep abreast of developments in York. Close working relationships have resulted in joint research, co-purchasing of equipment, sponsorship of Chairs at the University of York, sharing of technician training facilities and equipment - and many other examples of collaboration which have produced real bottom line benefits for all those involved. Key partners: City of York Council, University of York (one of the UK's top 10 research universities; Smith & Nephew (whose Group Research Centre is located on York Science Park, part of the University campus); Central Science Laboratory (CSL) (the research agency of the Ministry of Agriculture, Fisheries and Food (MAFF)). Also involved are CBAMS Ltd, the only centre for accelerator mass spectrometry in Europe dedicated to biomedical research (based at CSL_ and Bioincubator York Ltd which provides mentoring, support services and investment funds for early stage biotechnology companies. Areas for potential collaboration include: Drug development; new agricultural products; technology transfer. Bioscience York offers immediate access to an established infrastructure and high quality research expertise. This includes; joint research and training initiatives, collaboration on human resources management and joint approaches to raising public awareness of bioscience.